My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 126

    1.

    Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

    Andrulionyte L, Kuulasmaa T, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

    Diabetes. 2007 Apr;56(4):1181-6. Epub 2007 Feb 22.PMID: 17317762 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.

    Andrulionytè L, Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

    Diabetologia. 2004 Dec;47(12):2176-84. Epub 2004 Dec 8.PMID: 15592662 [PubMed - indexed for MEDLINE]Related articles

    3.

    Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

    Andrulionyte L, Peltola P, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

    Diabetes. 2006 Jul;55(7):2148-52.PMID: 16804087 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

    Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

    Diabetes. 2005 Mar;54(3):893-9.PMID: 15734870 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.

    Andrulionyte L, Laukkanen O, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

    J Mol Med. 2006 Aug;84(8):701-8. Epub 2006 Jul 13.PMID: 16838170 [PubMed - indexed for MEDLINE]Related articles

    6.

    The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.

    Fanelli M, Filippi E, Sentinelli F, Romeo S, Fallarino M, Buzzetti R, Leonetti F, Baroni MG.

    Dis Markers. 2005;21(4):175-80.PMID: 16403952 [PubMed - indexed for MEDLINE]Related articles

    7.

    The peroxisome proliferator-activated receptor gamma coactivator-1 alpha gene (PGC-1alpha) is not associated with type 2 diabetes mellitus or body mass index among Hispanic and non Hispanic Whites from Colorado.

    Nelson TL, Fingerlin TE, Moss L, Barmada MM, Ferrell RE, Norris JM.

    Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):268-75.PMID: 17479445 [PubMed - indexed for MEDLINE]Related articles

    8.

    Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.

    Kubaszek A, Pihlajamäki J, Komarovski V, Lindi V, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study.

    Diabetes. 2003 Jul;52(7):1872-6.PMID: 12829659 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.

    Laukkanen O, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study.

    Diabetes. 2005 Jul;54(7):2256-60.PMID: 15983230 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.

    Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ, Ayyobi A, Pimstone S, Frohlich J, Ansquer JC, Steiner G; DAIS investigators.

    Pharmacogenetics. 2004 Dec;14(12):823-9.PMID: 15608561 [PubMed - indexed for MEDLINE]Related articles

    11.

    The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

    Zacharova J, Todorova BR, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

    J Intern Med. 2005 Feb;257(2):185-93.PMID: 15656877 [PubMed - indexed for MEDLINE]Related articles

    12.

    The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).

    Tai ES, Collins D, Robins SJ, O'Connor JJ Jr, Bloomfield HE, Ordovas JM, Schaefer EJ, Brousseau ME.

    Atherosclerosis. 2006 Jul;187(1):153-60. Epub 2005 Oct 10.PMID: 16221474 [PubMed - indexed for MEDLINE]Related articles

    13.

    Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.

    Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, Hurel SJ, Humphries SE.

    Diabetes. 2005 Feb;54(2):582-6.PMID: 15677519 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    SNPs in PPARG associate with type 2 diabetes and interact with physical activity.

    Kilpeläinen TO, Lakka TA, Laaksonen DE, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Lindi V, Tuomilehto J, Uusitupa M, Laakso M.

    Med Sci Sports Exerc. 2008 Jan;40(1):25-33.PMID: 18091023 [PubMed - indexed for MEDLINE]Related articles

    15.

    Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial.

    Chiasson JL.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:25-30. Review.PMID: 16627376 [PubMed - indexed for MEDLINE]Related articles

    16.

    Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance.

    Zacharova J, Chiasson JL, Laakso M.

    Obes Res. 2005 Mar;13(3):501-6.PMID: 15833934 [PubMed - indexed for MEDLINE]Related articles

    17.

    Association between peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene polymorphisms and type 2 diabetes in southern Chinese population: role of altered interaction with myocyte enhancer factor 2C.

    Zhang SL, Lu WS, Yan L, Wu MC, Xu MT, Chen LH, Cheng H.

    Chin Med J (Engl). 2007 Nov 5;120(21):1878-85.PMID: 18067759 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients.

    Hansen L, Ekstrøm CT, Tabanera Y Palacios R, Anant M, Wassermann K, Reinhardt RR.

    J Clin Endocrinol Metab. 2006 Sep;91(9):3446-50. Epub 2006 Jul 5.PMID: 16822823 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study.

    Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E.

    Am J Clin Nutr. 2008 Jun;87(6):1926-31.PMID: 18541586 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.

    Todorova B, Kubaszek A, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study.

    J Clin Endocrinol Metab. 2004 May;89(5):2019-23.PMID: 15126514 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity